Avil antibody - N-terminal region (ARP31494_P050)
- Known as:
- Avil (anti-) - N-terminal region (ARP31494_P050)
- Catalog number:
- arp31494_p050
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Aviva Systems Biology
- Gene target:
- Avil antibody - N-terminal region (ARP31494_P050)
Related genes to: Avil antibody - N-terminal region (ARP31494_P050)
- Gene:
- AVIL NIH gene
- Name:
- advillin
- Previous symbol:
- -
- Synonyms:
- p92, FLJ12386, ADVIL, DOC6
- Chromosome:
- 12q14.1
- Locus Type:
- gene with protein product
- Date approved:
- 2002-09-02
- Date modifiied:
- 2015-09-11
Related products to: Avil antibody - N-terminal region (ARP31494_P050)
Related articles to: Avil antibody - N-terminal region (ARP31494_P050)
- - Source: PubMed
Publication date: 2026/07/01
Niranjan VijayGaurav PrashantKushwaha Ankit - Pheniramine maleate, a first-generation over-the-counter antihistamine, is widely used to treat allergies and as a sedative. However, its irrational use may result in drug-safety problems and threaten human health. Therefore, methods for rapidly detecting pheniramine have been widely studied and are significant from a practical perspective. In this study, we used electrospinning and hydrothermal methods to grow NiCo-based layered double hydroxide (LDH) nanosheets on the surfaces of carbon nanofibers (CNFs) and prepare NiCo-LDHs@CNF-based electrochemiluminescence sensors for the highly sensitive detection of pheniramine. The results show that both Ni and Co elements in NiCo-LDHs have multiple valence states. During the electrochemical process, these metal ions can rapidly and reversibly transform into each other among different valence states, forming efficient surface REDOX pairs. However, pure NiCo-LDHs tend to accumulate on the electrode surface. Therefore, in the prepared NiCo-LDHs@CNFs, CNFs act as the central skeleton to firmly support NiCo-LDHs, endowing them with high catalytic activity, high electrical conductivity, large specific surface area and excellent structural stability. The electrochemiluminescent sensor exhibited a detection limit of 8.6 × 10 mol/L in the 1 × 10 to 6 × 10 mol/L range, with a coefficient of determination of 0.9997. The sensor delivered a recovery rate of 97.1-103.4% and a relative standard deviation of less than 5%. Accordingly, the NiCo-LDHs@CNF electrochemiluminescence platform is expected to provide reliable technical support for drug concentration analysis. - Source: PubMed
Publication date: 2026/08/08
Zhang YiJing QiaolingZhu XuwenCheng ZihanTong YuqingCheng Hao - Repeat expansion mutations underlie diverse neurogenetic disorders, many involving the peripheral nervous system. Despite peripheral neuropathy being the most common neurological disorder worldwide, its contribution to repeat expansion diseases remains poorly defined, and robust preclinical models are limited. We established a translational framework to study peripheral neuropathy in spinocerebellar ataxia type 3 (SCA3), a fatal multisystem disorder caused by a pathogenic CAG expansion in ATXN3. - Source: PubMed
Publication date: 2026/07/31
Mato Juan PHayes John MEmerson JacenSridharan MaehaAdelaja ToluwaniNaeem ArsalPutka Alexandra FMcLoughlin Hayley S - The main objective of this study is to characterize self-medication Pharmaceutical Interventions (PI) carried out between 2017 and 2025. - Source: PubMed
Publication date: 2026/07/09
Bedhomme SabrinaPradeleix PierreMartinet ElodieRamos InesMartineau DelphineLafarge ElodiePereton BénédicteSavanovitch Chantal - The increasing incidence of jellyfish stings from expanding global marine activities necessitates painless therapeutic strategies with real-time treatment assessment capabilities. Here, we present a bioinspired core-shell photonic crystal microneedle (PCMN) patch that addresses this need through dual functionality of both therapeutic delivery and optically transduced monitoring. This device is fabricated by coating hyaluronic acid (HA) shells onto non-close-packed PCMN cores, which are functionalized with chlorpheniramine, while the HA shells incorporate lidocaine as a pain management payload. Upon skin insertion, the patch achieves distinct release profiles of lidocaine (from the shell) and chlorpheniramine (from the core), which are consistent with a structure-dependent release mechanism, addressing the distinct temporal requirements of jellyfish envenomation. Critically, this drug release process is accompanied by measurable shifts in the reflection spectrum, enabling real-time and quantifiable optical monitoring of the release process. The quantitative assessment of drug release can be achieved through the position of the reflection peak in an in vitro agarose-phantom model, allowing direct calibration of treatment progress with simple and portable devices. In a murine model of jellyfish sting envenomation, the PCMN@HA platform demonstrated partially attenuated systemic envenomation within 7 h. This work establishes a theranostic platform that integrates a biomimetic device design with optical signal readout, with potential applications extending to other dermatological conditions requiring temporally controlled pharmacotherapy. - Source: PubMed
Publication date: 2026/07/20
Sun YouhaoLi HanwenDong ZihanLi QinyuanXu ChunchaoZeng XiaohanQi FenglianDing Caifeng